Viewing Study NCT00655551


Ignite Creation Date: 2025-12-24 @ 11:50 PM
Ignite Modification Date: 2026-02-25 @ 7:22 PM
Study NCT ID: NCT00655551
Status: COMPLETED
Last Update Posted: 2018-07-17
First Post: 2008-03-26
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures
Sponsor: UCB BIOSCIENCES, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Partial Epilepsies View
None Partial Onset Seizures View
Keywords:

Keywords

Keyword Brief Keyword Text View
None epilepsy View
None seizures View
None Lacosamide View
None intravenous View
None Vimpat View